IMMX insider filings

Immix Biopharma, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-20. Screen IMMX transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 2 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Morris Gabriel S — CFO, President, Director11 leg · 1,418 sh · $10,011——
Rachman Ilya M — CEO, Chairman, Director11 leg · 1,408 sh · $10,000——

Recent insider filings — Immix Biopharma, Inc.

FiledFormInsiderReported transactionsSource
2026-11-204Morris Gabriel S — CFO, President, DirectorPurchase (P): 1,418 @ $7.06EDGAR
2026-11-204Rachman Ilya M — CEO, Chairman, DirectorPurchase (P): 1,408.45 @ $7.10EDGAR
2026-05-294Ng Carey — DirectorGrant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2026-05-294Morris Gabriel S — CFO, President, DirectorGrant/award (A): 500,000 (derivative) @ $0EDGAR
2026-05-294Rachman Ilya M — CEO and Chairman, DirectorGrant/award (A): 500,000 (derivative) @ $0EDGAR
2026-05-294Chudnovsky Yekaterina — DirectorGrant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2026-05-294Hsu Jason — DirectorGrant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2026-05-294Marquet Magda — DirectorGrant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2026-05-294Adams Helen C. — DirectorGrant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2026-05-294BUCHAN JANE — DirectorGrant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2026-05-294CHANG NANCY T — DirectorGrant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2025-12-114CHANG NANCY T — DirectorGrant/award (A): 39,643 (derivative) @ $0EDGAR
2025-12-104Rachman Ilya M — CEO and Chairman, DirectorPurchase (P): 746 @ $6.67EDGAR
2025-12-104Morris Gabriel S — CFO, DirectorOption exercise/expiry (X): 156,000 @ $0.80 · Purchase (P): 770 @ $6.58 · Option exercise/expiry (X): 96,000 (derivative) @ $0 · Option exercise/expiry (X): 60,000 (derivative) @ $0EDGAR
2025-09-174Rachman Ilya M — CEO and Chairman, DirectorPurchase (P): 2,500 @ $2.02EDGAR
2025-09-174Morris Gabriel S — CFO, DirectorPurchase (P): 2,600 @ $1.97EDGAR
2025-06-234Rachman Ilya M — CEO and Chairman, DirectorGrant/award (A): 340,000 (derivative) @ $0EDGAR
2025-06-234Ng Carey — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2025-06-234Morris Gabriel S — CFO, DirectorGrant/award (A): 340,000 (derivative) @ $0EDGAR
2025-06-234Hsu Jason — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2025-06-234Chudnovsky Yekaterina — Director, 10% ownerGrant/award (A): 33,000 (derivative) @ $0EDGAR
2025-06-234Marquet Magda — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2025-06-234Adams Helen C. — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2025-06-234BUCHAN JANE — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2025-06-204Rachman Ilya M — CEO and Chairman, DirectorPurchase (P): 2,178 @ $2.29EDGAR
2025-06-204Morris Gabriel S — CFO, DirectorPurchase (P): 2,225 @ $2.28EDGAR
2024-12-264Hsu Jason — DirectorPurchase (P): 7,700 @ $2.17 · Purchase (P): 40,000 @ $2.19EDGAR
2024-08-264Hsu Jason — DirectorPurchase (P): 15,000 @ $2.23 · Purchase (P): 8,100 @ $2.25EDGAR
2024-08-194Ng Carey — DirectorPurchase (P): 10,000 @ $1.86EDGAR
2024-07-314Hsu Jason — DirectorPurchase (P): 3,200 @ $2.07 · Purchase (P): 6,000 @ $2.15EDGAR
2024-06-214Rachman Ilya M — CEO and Chairman, DirectorGrant/award (A): 340,000 (derivative) @ $0EDGAR
2024-06-214Ng Carey — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2024-06-214Morris Gabriel S — CFO, DirectorGrant/award (A): 340,000 (derivative) @ $0EDGAR
2024-06-214Hsu Jason — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2024-06-214Chudnovsky Yekaterina — Director, 10% ownerGrant/award (A): 33,000 (derivative) @ $0EDGAR
2024-06-214Marquet Magda — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2024-06-214Adams Helen C. — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2024-06-214BUCHAN JANE — DirectorGrant/award (A): 33,000 (derivative) @ $0EDGAR
2024-06-104Morris Gabriel S — CFO, DirectorPurchase (P): 2,500 @ $2.12EDGAR
2024-06-104Rachman Ilya M — CEO and Chairman, DirectorPurchase (P): 2,600 @ $2.13EDGAR
2024-06-054Morris Gabriel S — CFO, DirectorPurchase (P): 3,300 @ $1.81EDGAR
2024-06-054Rachman Ilya M — CEO and Chairman, DirectorPurchase (P): 3,300 @ $1.81EDGAR
2024-05-204Hsu Jason — DirectorGrant/award (A): 21,587 (derivative) @ $0 · Grant/award (A): 25,512 (derivative) @ $0EDGAR
2024-05-204Rachman Ilya M — CEO and Chairman, DirectorGrant/award (A): 218,359EDGAR
2024-05-204Morris Gabriel S — CFO, DirectorGrant/award (A): 194,218 · Grant/award (A): 24,141 · Grant/award (A): 24,141EDGAR
2024-05-204Ng Carey — DirectorGrant/award (A): 21,587 (derivative) @ $0 · Grant/award (A): 25,512 (derivative) @ $0EDGAR
2024-05-204Marquet Magda — DirectorGrant/award (A): 25,002 @ $0 · Grant/award (A): 21,155EDGAR
2024-05-204Adams Helen C. — DirectorGrant/award (A): 87,740 @ $0 · Grant/award (A): 74,241EDGAR
2024-05-204BUCHAN JANE — DirectorGrant/award (A): 1,332 @ $0 · Grant/award (A): 1,127 · Grant/award (A): 20,436 (derivative) @ $0 · Grant/award (A): 24,153 (derivative) @ $0EDGAR
2024-05-144Rachman Ilya M — CEO and Chairman, DirectorPurchase (P): 4,300 @ $2.25EDGAR

Recent 8-K events — Immix Biopharma, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-308-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-298-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-208-K8.01 — Other EventsEDGAR
2026-05-298-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-218-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-218-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-308-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-258-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-088-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=IMMX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs